Long-term use of cardiovascular drugs may reduce dementia risk in older adults by up to 25%, while antiplatelet drugs could ...

The revenue generated in the Anti-Hypertensive Drugs market in Germany is forecasted to reach US$803.10m in 2024. It is expected to exhibit an annual growth rate (CAGR 2024-2029) of -0.17% ...

The India-based trial, the first of its kind, confirmed that systolic BP levels decreased no matter the exact mix of three ...

THERE’S currently no cure for dementia and while there’s no guaranteed way to prevent it, certain things can reduce your risk ...

In Vietnam, the revenue in the Anti-Hypertensive Drugs market is estimated to reach US$41.37m by 2024. It is expected to exhibit an annual growth rate (CAGR 2024-2029) of 0.92%, leading to a ...

The study, published in Alzheimer's & Dementia on Monday, highlighted four common heart drugs that may lower your dementia ...

A recent study suggests that commonly used cardiovascular medications are associated with a reduced risk of dementia in older ...

Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new study from Karolinska ...

Tryvio TM (aprocitentan) is now available for the treatment of hypertension in combination with other antihypertensive drugs, to lower blood pressure (BP) in adult patients who are not adequately ...

Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new study. Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to ...

Discover how ultrasound renal denervation offers long-term blood pressure control and reduces medication needs in resistant ...